S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.36 (+1.94%)
AAPL   172.06 (+2.12%)
MSFT   291.92 (+1.71%)
META   180.27 (+1.57%)
GOOGL   121.54 (+2.27%)
AMZN   143.42 (+1.98%)
TSLA   899.89 (+4.65%)
NVDA   187.09 (+4.27%)
NIO   21.05 (+1.10%)
BABA   94.64 (-0.24%)
AMD   100.74 (+2.67%)
MU   64.94 (+4.20%)
T   18.23 (+1.05%)
CGC   3.30 (+4.76%)
GE   79.94 (+1.32%)
F   16.18 (+2.21%)
DIS   121.41 (+3.16%)
AMC   24.53 (-3.65%)
PYPL   100.90 (+1.81%)
PFE   50.11 (+3.77%)
NFLX   249.03 (+2.61%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.36 (+1.94%)
AAPL   172.06 (+2.12%)
MSFT   291.92 (+1.71%)
META   180.27 (+1.57%)
GOOGL   121.54 (+2.27%)
AMZN   143.42 (+1.98%)
TSLA   899.89 (+4.65%)
NVDA   187.09 (+4.27%)
NIO   21.05 (+1.10%)
BABA   94.64 (-0.24%)
AMD   100.74 (+2.67%)
MU   64.94 (+4.20%)
T   18.23 (+1.05%)
CGC   3.30 (+4.76%)
GE   79.94 (+1.32%)
F   16.18 (+2.21%)
DIS   121.41 (+3.16%)
AMC   24.53 (-3.65%)
PYPL   100.90 (+1.81%)
PFE   50.11 (+3.77%)
NFLX   249.03 (+2.61%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.36 (+1.94%)
AAPL   172.06 (+2.12%)
MSFT   291.92 (+1.71%)
META   180.27 (+1.57%)
GOOGL   121.54 (+2.27%)
AMZN   143.42 (+1.98%)
TSLA   899.89 (+4.65%)
NVDA   187.09 (+4.27%)
NIO   21.05 (+1.10%)
BABA   94.64 (-0.24%)
AMD   100.74 (+2.67%)
MU   64.94 (+4.20%)
T   18.23 (+1.05%)
CGC   3.30 (+4.76%)
GE   79.94 (+1.32%)
F   16.18 (+2.21%)
DIS   121.41 (+3.16%)
AMC   24.53 (-3.65%)
PYPL   100.90 (+1.81%)
PFE   50.11 (+3.77%)
NFLX   249.03 (+2.61%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.36 (+1.94%)
AAPL   172.06 (+2.12%)
MSFT   291.92 (+1.71%)
META   180.27 (+1.57%)
GOOGL   121.54 (+2.27%)
AMZN   143.42 (+1.98%)
TSLA   899.89 (+4.65%)
NVDA   187.09 (+4.27%)
NIO   21.05 (+1.10%)
BABA   94.64 (-0.24%)
AMD   100.74 (+2.67%)
MU   64.94 (+4.20%)
T   18.23 (+1.05%)
CGC   3.30 (+4.76%)
GE   79.94 (+1.32%)
F   16.18 (+2.21%)
DIS   121.41 (+3.16%)
AMC   24.53 (-3.65%)
PYPL   100.90 (+1.81%)
PFE   50.11 (+3.77%)
NFLX   249.03 (+2.61%)
TSE:JWEL

Jamieson Wellness - JWEL Stock Forecast, Price & News

C$37.28
-0.27 (-0.72%)
(As of 08/12/2022 04:00 PM ET)
Add
Compare
Today's Range
C$36.81
C$37.49
50-Day Range
C$33.96
C$38.06
52-Week Range
C$32.02
C$41.74
Volume
17,122 shs
Average Volume
66,136 shs
Market Capitalization
C$1.55 billion
P/E Ratio
28.90
Dividend Yield
1.81%
Price Target
C$44.16
JWEL stock logo

About Jamieson Wellness (TSE:JWEL) Stock

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells natural health products in Canada and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and Lorna Vanderhaeghe brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands. The Strategic Partners segment provides manufacturing and product development services on a contract manufacturing basis to blue-chip consumer health companies and retailers. Jamieson Wellness Inc. sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.

Wall Street Analyst Weigh In

Several brokerages recently commented on JWEL. CIBC lifted their target price on shares of Jamieson Wellness from C$42.00 to C$45.00 and gave the stock an "outperform" rating in a research note on Thursday, June 2nd. Scotiabank upped their price objective on shares of Jamieson Wellness from C$37.00 to C$39.00 in a research note on Thursday, June 2nd. Royal Bank of Canada cut their target price on Jamieson Wellness from C$46.00 to C$45.00 and set an "outperform" rating on the stock in a research note on Friday, August 5th. TD Securities upped their price target on Jamieson Wellness from C$45.00 to C$50.00 and gave the company a "buy" rating in a research report on Thursday, June 2nd. Finally, Eight Capital lifted their price objective on Jamieson Wellness from C$44.00 to C$46.00 and gave the stock a "na" rating in a research report on Thursday, June 2nd. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of C$44.16.

Jamieson Wellness Stock Down 0.7 %

Shares of TSE:JWEL opened at C$37.55 on Friday. The firm has a market capitalization of C$1.56 billion and a P/E ratio of 28.23. The company has a debt-to-equity ratio of 46.51, a quick ratio of 1.19 and a current ratio of 2.83. The stock has a 50 day moving average price of C$35.76 and a 200-day moving average price of C$34.99. Jamieson Wellness has a 52-week low of C$32.02 and a 52-week high of C$41.74.

Jamieson Wellness Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 15th. Shareholders of record on Wednesday, June 15th were given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend was Monday, May 30th. Jamieson Wellness's dividend payout ratio is currently 45.11%.

Receive JWEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jamieson Wellness and its competitors with MarketBeat's FREE daily newsletter.

JWEL Stock News Headlines

Jamieson Wellness Inc stock raised on Friday.
Jamieson Wellness Inc stock advanced on Thursday.
Jamieson Wellness Inc stock eased on Tuesday.
See More Headlines
Receive JWEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jamieson Wellness and its competitors with MarketBeat's FREE daily newsletter.

JWEL Company Calendar

Ex-Dividend for 6/15 Dividend
5/30/2022
Dividend Payable
6/15/2022
Today
8/12/2022

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
110
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$44.16
High Stock Price Forecast
C$50.00
Low Stock Price Forecast
C$39.00
Forecasted Upside/Downside
+18.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$457.87 million
Cash Flow
C$0.34 per share
Book Value
C$8.85 per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.55 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Michael Pilato (Age 47)
    Pres, CEO & Director
    Comp: $1.36M
  • Mr. Christopher Snowden
    CFO & Corp. Sec.
  • Ms. Regan Stewart
    Chief Operations & People Officer
  • Mr. John Doherty (Age 49)
    Chief Science & Innovation Officer
    Comp: $753.62k
  • Mr. Don Bird (Age 58)
    Exec. VP of USA & Global Strategic Partners
    Comp: $777.44k
  • Ruth Winker
    Corp. Communications Director
  • Mr. Eric Bentz
    Sr. VP of Global Marketing & MD of China
  • Mr. Paul Galbraith
    Sr. VP & MD of Canada
  • Mr. Joel Scales
    Exec. VP of Jamieson Worldwide, Global Strategy & E-Commerce













JWEL Stock - Frequently Asked Questions

Should I buy or sell Jamieson Wellness stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Jamieson Wellness in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" JWEL shares.
View JWEL analyst ratings
or view top-rated stocks.

What is Jamieson Wellness' stock price forecast for 2022?

6 brokers have issued 1 year price targets for Jamieson Wellness' shares. Their JWEL share price forecasts range from C$39.00 to C$50.00. On average, they anticipate the company's stock price to reach C$44.16 in the next twelve months. This suggests a possible upside of 19.1% from the stock's current price.
View analysts price targets for JWEL
or view top-rated stocks among Wall Street analysts.

How have JWEL shares performed in 2022?

Jamieson Wellness' stock was trading at C$40.14 at the beginning of the year. Since then, JWEL stock has decreased by 7.6% and is now trading at C$37.07.
View the best growth stocks for 2022 here
.

How often does Jamieson Wellness pay dividends? What is the dividend yield for Jamieson Wellness?

Jamieson Wellness declared a quarterly dividend on Monday, May 30th. Investors of record on Wednesday, June 15th will be given a dividend of 0.15 per share on Wednesday, June 15th. This represents a $0.60 annualized dividend and a dividend yield of 1.62%. The ex-dividend date is Monday, May 30th.
Read our dividend analysis for JWEL
.

Is Jamieson Wellness a good dividend stock?

Jamieson Wellness (TSE:JWEL) pays an annual dividend of C$0.60 per share and currently has a dividend yield of 1.81%. The dividend payout ratio is 45.11%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for JWEL.

What other stocks do shareholders of Jamieson Wellness own?

What is Jamieson Wellness' stock symbol?

Jamieson Wellness trades on the Toronto Stock Exchange (TSX) under the ticker symbol "JWEL."

How do I buy shares of Jamieson Wellness?

Shares of JWEL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Jamieson Wellness' stock price today?

One share of JWEL stock can currently be purchased for approximately C$37.07.

How much money does Jamieson Wellness make?

Jamieson Wellness (TSE:JWEL) has a market capitalization of C$1.54 billion and generates C$456.44 million in revenue each year.

How many employees does Jamieson Wellness have?

The company employs 110 workers across the globe.

How can I contact Jamieson Wellness?

Jamieson Wellness' mailing address is 2 St. Clair Avenue West, TORONTO, ON M4V 1L5, Canada. The official website for the company is investors.jamiesonwellness.com. The company can be reached via phone at +1-416-9600052.

This page (TSE:JWEL) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.